Omnia Family Wealth’s AstraZeneca AZN Stock Holding History

Omnia Family Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-785	Closed	-$63K	–	136
2019 Q1	$63K	Hold	785	–	–	0.03%	145
2018 Q4	$60K	Hold	785	–	–	0.03%	141
2018 Q3	$62K	Sell	785 -85	-10%	-$6.43K	0.03%	144
2018 Q2	$61K	Hold	870	–	–	0.03%	142
2018 Q1	$61K	Hold	870	–	–	0.03%	140
2017 Q4	$60K	Hold	870	–	–	0.03%	143
2017 Q3	$59K	Hold	870	–	–	0.03%	139
2017 Q2	$59K	Sell	870 -819	-48%	-$53.5K	0.03%	142
2017 Q1	$105K	Hold	1,689	–	–	0.05%	115
2016 Q4	$92K	Buy	+1,689	New	+$95.9K	0.05%	126

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Omnia Family Wealth's AZN Position: Q2 2019 in Review

Omnia Family Wealth sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 785 shares — an estimated $63K sold.

Omnia Family Wealth first reported a position in AZN in Q4 2016 and held it in 10 quarters. The position peaked at $105K in Q1 2017. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Omnia Family Wealth reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
Omnia Family Wealth sold 785 AstraZeneca shares in Q2 2019, an estimated $63K.
Omnia Family Wealth first reported a position in AstraZeneca in Q4 2016 and held it in 10 quarters.
Omnia Family Wealth's AstraZeneca position peaked at $105K in Q1 2017.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Omnia Family Wealth's 13F filing for Q2 2019, filed 7 Aug 2019.